These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 39050757)
1. Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily. Digles D; Ingles-Prieto A; Dvorak V; Mocking TAM; Goldmann U; Garofoli A; Homan EJ; Di Silvio A; Azzollini L; Sassone F; Fogazza M; Bärenz F; Pommereau A; Zuschlag Y; Ooms JF; Tranberg-Jensen J; Hansen JS; Stanka J; Sijben HJ; Batoulis H; Bender E; Martini R; IJzerman AP; Sauer DB; Heitman LH; Manolova V; Reinhardt J; Ehrmann A; Leippe P; Ecker GF; Huber KVM; Licher T; Scarabottolo L; Wiedmer T; Superti-Furga G Front Pharmacol; 2024; 15():1401599. PubMed ID: 39050757 [TBL] [Abstract][Full Text] [Related]
2. An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Dvorak V; Wiedmer T; Ingles-Prieto A; Altermatt P; Batoulis H; Bärenz F; Bender E; Digles D; Dürrenberger F; Heitman LH; IJzerman AP; Kell DB; Kickinger S; Körzö D; Leippe P; Licher T; Manolova V; Rizzetto R; Sassone F; Scarabottolo L; Schlessinger A; Schneider V; Sijben HJ; Steck AL; Sundström H; Tremolada S; Wilhelm M; Wright Muelas M; Zindel D; Steppan CM; Superti-Furga G Front Pharmacol; 2021; 12():722889. PubMed ID: 34447313 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system. Clémençon B; Lüscher BP; Hediger MA J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877 [TBL] [Abstract][Full Text] [Related]
4. Structural and functional annotation of solute carrier transporters: implication for drug discovery. Dvorak V; Superti-Furga G Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933 [TBL] [Abstract][Full Text] [Related]
5. The solute carrier transporters and the brain: Physiological and pharmacological implications. Hu C; Tao L; Cao X; Chen L Asian J Pharm Sci; 2020 Mar; 15(2):131-144. PubMed ID: 32373195 [TBL] [Abstract][Full Text] [Related]
6. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities. Schlessinger A; Zatorski N; Hutchinson K; Colas C Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450 [TBL] [Abstract][Full Text] [Related]
7. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers. Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987 [TBL] [Abstract][Full Text] [Related]
8. A rapid and simple non-radioactive assay for measuring uptake by solute carrier transporters. Song K; Zhang L; Fu X; Li L; Zhu G; Wu M; Zhang W; He J; Zhu S; Dang Y; Liu JY; Chen C; Guo Z Front Pharmacol; 2024; 15():1355507. PubMed ID: 38720778 [No Abstract] [Full Text] [Related]
9. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy. Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513 [TBL] [Abstract][Full Text] [Related]
10. A substrate-based ontology for human solute carriers. Meixner E; Goldmann U; Sedlyarov V; Scorzoni S; Rebsamen M; Girardi E; Superti-Furga G Mol Syst Biol; 2020 Jul; 16(7):e9652. PubMed ID: 32697042 [TBL] [Abstract][Full Text] [Related]
11. The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of Bilaterian species. Höglund PJ; Nordström KJ; Schiöth HB; Fredriksson R Mol Biol Evol; 2011 Apr; 28(4):1531-41. PubMed ID: 21186191 [TBL] [Abstract][Full Text] [Related]
12. Structural biology of solute carrier (SLC) membrane transport proteins. Bai X; Moraes TF; Reithmeier RAF Mol Membr Biol; 2017; 34(1-2):1-32. PubMed ID: 29651895 [TBL] [Abstract][Full Text] [Related]
13. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies. Ceder MM; Fredriksson R Gene; 2022 Jan; 809():146033. PubMed ID: 34673204 [TBL] [Abstract][Full Text] [Related]
14. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease. Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442 [TBL] [Abstract][Full Text] [Related]
15. Advances and Challenges in Rational Drug Design for SLCs. Garibsingh RA; Schlessinger A Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459 [TBL] [Abstract][Full Text] [Related]
16. Solute carriers as drug targets: current use, clinical trials and prospective. Rask-Andersen M; Masuram S; Fredriksson R; Schiöth HB Mol Aspects Med; 2013; 34(2-3):702-10. PubMed ID: 23506903 [TBL] [Abstract][Full Text] [Related]
17. Heterologous (Over) Expression of Human SoLute Carrier (SLC) in Yeast: A Well-Recognized Tool for Human Transporter Function/Structure Studies. Pochini L; Galluccio M Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013385 [TBL] [Abstract][Full Text] [Related]
18. The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis. Sun LL; He HY; Li W; Jin WL; Wei YJ Biomark Res; 2024 Sep; 12(1):94. PubMed ID: 39218897 [TBL] [Abstract][Full Text] [Related]
19. Identification and subtype analysis of biomarkers associated with the solute carrier family in acute myocardial infarction. Qi Z; Pu Y; Guo H; Tang W; Xiong Y; Ran B Medicine (Baltimore); 2023 Dec; 102(49):e36515. PubMed ID: 38065877 [TBL] [Abstract][Full Text] [Related]
20. The Role of Transporters in Future Chemotherapy. Huttunen J; Huttunen KM Chimia (Aarau); 2022 May; 76(5):454-459. PubMed ID: 38069717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]